REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,527,193 | -13.8% | 2,383,000 | -0.0% | 0.10% | -12.3% |
| Q1 2023 | $2,931,980 | -62.1% | 2,384,000 | -71.6% | 0.11% | -62.1% |
| Q4 2022 | $7,742,903 | -31.8% | 8,399,000 | -19.2% | 0.30% | -31.0% |
| Q3 2022 | $11,355,000 | +97.4% | 10,399,000 | +111.4% | 0.44% | +153.5% |
| Q2 2021 | $5,752,000 | -24.7% | 4,918,000 | -28.9% | 0.17% | -34.6% |
| Q1 2021 | $7,639,000 | – | 6,918,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |